Updates on Dengue Vaccine and Antiviral: Where Are We Heading?
Approximately 100–400 million people from more than 100 countries in the tropical and subtropical world are affected by dengue infections. Recent scientific breakthroughs have brought new insights into novel strategies for the production of dengue antivirals and vaccines. The search for specific den...
Saved in:
Main Authors: | Harun Norshidah, Ramachandran Vignesh, Ngit Shin Lai |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/dc66ccf0fba94e56aa7bec795ec99b09 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diterpenes/Diterpenoids and Their Derivatives as Potential Bioactive Leads against Dengue Virus: A Computational and Network Pharmacology Study
by: Rasel Ahmed Khan, et al.
Published: (2021) -
Occurrence of Dengue Virus Infection with Multiple Serotypes at Central Karnataka, India
by: VinodKumar CS, et al.
Published: (2021) -
A Critical Role for Perivascular Cells in Amplifying Vascular Leakage Induced by Dengue Virus Nonstructural Protein 1
by: Yin P. Cheung, et al.
Published: (2020) -
NS1-based ELISA test efficiently detects dengue infections without cross-reactivity with Zika virus
by: Samuel Santos Pereira, et al.
Published: (2021) -
Efficient Control of Zika Virus Infection Induced by a Non-Replicating Adenovector Encoding Zika Virus NS1/NS2 Antigens Fused to the MHC Class II-Associated Invariant Chain
by: Loulieta Nazerai, et al.
Published: (2021)